General
PRRC & the 2023 MDCG Guidance: What Small Manufacturers Need to Know
Given the clarifications in the December 2023 MDCG guidance on the role of the Person Responsible for Regulatory Compliance (PRRC), how should medical device manufacturers, particularly small or micro-enterprises, re-evaluate their arrangements with "PRRC as a Service" providers? Beyond verifying the provider's qualifications under EU MDR Article 15, what specific contractual and procedural mechanisms are now essential to demonstrate compliance?
For instance, how can a manufacturer contractually ensure and document the "continuous and permanent availability" of an external PRRC, as emphasized by the guidance? What objective evidence should be maintained to prove the outsourced PRRC is not just a signatory but is genuinely integrated into the manufacturer's Quality Management System (QMS)? This includes demonstrating their active involvement in key processes such as reviewing the conformity of devices before release, overseeing the creation and maintenance of technical documentation, and fulfilling post-market surveillance and vigilance reporting obligations.
Furthermore, how should service agreements be structured to guarantee the PRRC has the necessary authority and unimpeded access to all relevant documentation, regardless of their external status? To what extent must the agreement detail the PRRC's operational independence and the manufacturer's obligation to act on their compliance-related advice? Effectively, what does a robust, audit-ready framework for an outsourced PRRC relationship look like in practice, moving from a nominal appointment to a demonstrably effective, integrated compliance function?
---
*This Q&A was AI-assisted and reviewed for accuracy by Lo H. Khamis.*
💬 1 answers
👁️ 27 views
👍 2
Asked by Lo H. Khamis
Answers
Lo H. Khamis
👍 3
Here is the processed text for the 'blog_agent' service.
***
## Outsourcing Your PRRC: A Guide to Compliance After the 2023 MDCG Guidance
Under the EU Medical Device Regulation (MDR), the role of the Person Responsible for Regulatory Compliance (PRRC) is a cornerstone of a manufacturer's quality and compliance framework. While larger organizations must appoint a PRRC internally, Article 15 of the MDR provides a crucial allowance for micro and small enterprises to outsource this function to a third-party expert. However, the convenience of outsourcing comes with significant responsibility.
The December 2023 Medical Device Coordination Group (MDCG) guidance on the PRRC role has clarified what regulators and Notified Bodies expect from these arrangements. The guidance effectively ends the era of the "paper PRRC"—a nominal appointee who merely signs documents without genuine involvement. It emphasizes that an outsourced PRRC must be "continuously and permanently available" and deeply integrated into the manufacturer's Quality Management System (QMS). For small manufacturers, this means re-evaluating their "PRRC as a Service" agreements to ensure they can provide objective evidence of a robust, functional, and compliant relationship. This article provides a detailed framework for structuring and documenting that relationship to withstand regulatory scrutiny.
### Key Points
* **Beyond a Name on Paper:** The 2023 MDCG guidance confirms that the outsourced PRRC must be an active, integrated member of the compliance function, not just a signatory. Manufacturers are responsible for proving this integration.
* **"Continuous Availability" Defined:** This term means more than just being reachable. The service agreement must contractually define response times, involvement in scheduled activities (like management reviews), and processes for urgent matters (like vigilance reporting).
* **Integration with the QMS is Non-Negotiable:** The PRRC’s responsibilities and interactions must be explicitly written into the manufacturer's QMS procedures, including processes for technical documentation review, batch release, and post-market surveillance.
* **The Contract is Your First Line of Defense:** A detailed service-level agreement is essential. It must grant the PRRC unimpeded access to all necessary documentation and the authority to ensure compliance, formalizing their operational independence.
* **Objective Evidence is Crucial for Audits:** Manufacturers must systematically create and maintain records that prove the PRRC's active involvement, such as meeting minutes, signed-off documents, and documented communication regarding compliance decisions.
### Understanding the Shift: From Nominal Appointment to Integrated Function
Before the 2023 MDCG guidance, some small manufacturers treated the outsourced PRRC requirement as a box-ticking exercise. They might engage a consultant with a minimal retainer, contacting them only when a signature was needed. This approach created a significant compliance risk, as the PRRC could not possibly fulfill their duties without deep, ongoing involvement in the manufacturer's operations.
The latest guidance clarifies that Notified Bodies and Competent Authorities will assess the *effectiveness* of the PRRC arrangement. They expect the manufacturer to demonstrate that the external PRRC has a genuine, functional role within the organization. The core principles emphasized are:
1. **Continuous and Permanent Availability:** The PRRC must be consistently accessible and integrated into the operational flow of the company. This ensures that compliance oversight is not an afterthought but a continuous process.
2. **Sufficient Time and Resources:** The manufacturer must ensure the outsourced PRRC has enough allocated time and resources to properly execute all responsibilities defined in Article 15. A low-cost, minimal-hours contract for a complex device portfolio would likely be seen as a red flag.
3. **Operational Independence:** The PRRC must have the authority to make compliance-focused decisions without undue pressure from commercial or manufacturing departments.
This shift means manufacturers must now focus on building a demonstrable, audit-ready framework that proves their outsourced PRRC is a fully-integrated part of their compliance system.
### Building an Audit-Ready Contractual Framework for Your Outsourced PRRC
The service agreement with your "PRRC as a Service" provider is the foundational document for your entire compliance arrangement. It must move beyond a simple list of duties to a detailed operational plan. A robust contract should include the following sections:
#### 1. Defining Availability and Communication Protocols
This section translates the vague requirement of "continuous and permanent availability" into concrete, measurable terms.
* **Response Times:** Specify expected response times for different levels of urgency (e.g., within 4 hours for potential vigilance events, 24-48 hours for routine QMS questions).
* **Scheduled Commitments:** Define the PRRC's required participation in key meetings, such as monthly/quarterly management reviews, design reviews for new products, and risk management reviews.
* **Availability for Unscheduled Events:** Outline the process for engaging the PRRC during an unannounced audit by a Notified Body or Competent Authority.
* **Backup/Deputy Designation:** The agreement should name a qualified deputy from the service provider who can step in if the primary PRRC is unavailable, ensuring true continuity.
#### 2. Detailing Specific Responsibilities and Deliverables
Do not simply copy and paste the five responsibilities from Article 15(3). Instead, detail *how* the PRRC will perform each task and what the documented output will be.
* **Conformity of Devices:** Specify that the PRRC must review and provide documented approval (e.g., a digital signature) of the Declaration of Conformity or batch release documentation *before* the product is placed on the market.
* **Technical Documentation:** Define the PRRC's role in the review and approval process for all new Technical Documentation and any significant changes. The procedure for this should be referenced in the agreement.
* **Post-Market Surveillance (PMS):** State that the PRRC will review and sign off on PMS plans and reports (e.g., PMSR, PSUR) according to the manufacturer's schedule.
* **Vigilance Reporting:** Clearly outline the PRRC’s role in investigating and making decisions on reportable events, including their interaction with the manufacturer's internal team.
* **Clinical Investigations:** For devices subject to clinical investigations, the contract must state the PRRC's responsibility for confirming the device's compliance with relevant requirements before the investigation begins.
#### 3. Granting Unimpeded Access and Authority
This is critical for demonstrating the PRRC's operational independence.
* **Access to Documentation:** The contract must explicitly grant the PRRC full and unrestricted access to the QMS, Technical Documentation, risk management file, PMS data, and any other relevant records.
* **Obligation to Inform:** Include a clause stating the manufacturer's obligation to proactively inform the PRRC of any significant changes, quality issues, or potential compliance risks.
* **Authority to Act:** The agreement must empower the PRRC to flag non-conformities and formally recommend corrective actions. It should also include a clause requiring the manufacturer to formally respond to and act upon the PRRC's compliance-related advice, documenting any instances where advice is not followed and the justification for doing so.
### Documenting Integration: How to Create Objective Evidence for an Audit
A strong contract is necessary, but it's not sufficient. During an audit, you will need to provide objective evidence that the contract is being executed as written. Manufacturers should systematically create and maintain the following records:
* **Updated QMS Documents:**
* **Organizational Chart:** The outsourced PRRC should be included, clearly showing their position and reporting lines within the compliance structure.
* **Relevant SOPs:** Procedures for final device release, change control, vigilance reporting, and PMS should explicitly name the PRRC as a required reviewer or approver.
* **Job Description:** Maintain a formal job description for the PRRC role that aligns with the service agreement and Article 15.
* **Records of Involvement:**
* **Meeting Minutes:** Agendas and minutes from management reviews, design reviews, and risk meetings should list the PRRC as an attendee and summarize their input.
* **Signed Documents:** Keep auditable records of all documents reviewed and approved by the PRRC, such as Declarations of Conformity, technical file review forms, and PMS reports. Use a system with time-stamped electronic signatures where possible.
* **Communication Logs:** Maintain key email correspondence or communication logs where the PRRC provides regulatory advice or makes compliance decisions. For example, document the email chain where the PRRC confirms that a specific complaint does not meet the criteria for a reportable vigilance event.
### Scenario Comparison
#### Scenario 1: The Non-Compliant "Paper" PRRC
A micro-enterprise signs a low-cost annual contract for a PRRC. The contract simply lists the responsibilities from Article 15. The PRRC's name is on the company's registration, but they are only contacted once per year to sign the annual management review. Their signature is not on any batch release records, and they have never seen the company's PMS plan.
* **Audit Outcome:** During a Notified Body audit, the auditor asks for evidence of the PRRC's involvement in the release of a recent batch. The manufacturer cannot provide any. This is identified as a major non-conformity, potentially jeopardizing the company's CE certification.
#### Scenario 2: The Audit-Ready Integrated PRRC
A small manufacturer has a detailed service agreement with a PRRC provider. Their QMS procedure for final product release requires a final quality check and a digital sign-off from the outsourced PRRC in their eQMS. The PRRC attends quarterly management reviews via video conference, and the minutes are recorded. When a serious complaint is received, the internal quality manager immediately initiates a documented workflow that includes the PRRC's assessment and final decision on whether to report it.
* **Audit Outcome:** The auditor asks for the same evidence. The manufacturer shows the auditor the signed batch release record in the eQMS, the meeting minutes with the PRRC's input, and the documented vigilance assessment signed by the PRRC. The auditor is satisfied that the PRRC is effectively integrated and fulfilling their responsibilities.
### Finding and Comparing PRRC as a Service (EU MDR) Providers
Choosing the right "PRRC as a Service" provider is a critical compliance decision. Beyond simply verifying qualifications, manufacturers should conduct a thorough evaluation of potential partners.
1. **Verify Qualifications and Experience:** Ask for concrete proof that the proposed PRRC meets the specific qualification requirements outlined in Article 15 of the EU MDR. Inquire about their direct experience with your device type and classification. A PRRC with a background in active implantables may not be the best fit for a Class I sterile device.
2. **Evaluate Their Service Model:** Discuss how they ensure "continuous and permanent availability." Do they have a team-based approach with qualified deputies? What are their standard communication protocols and guaranteed response times?
3. **Scrutinize the Service Agreement:** Review their standard contract. Does it already include detailed clauses on QMS integration, unimpeded access to documents, and the authority to act? A provider who understands the latest MDCG guidance will offer a contract that reflects these requirements.
4. **Discuss the Onboarding and Integration Process:** Ask them to walk you through their process for integrating with a new client's QMS. A high-quality provider will have a structured onboarding plan to review your procedures and establish clear operational workflows from day one.
Finding a provider who acts as a true partner in compliance is essential for navigating the complexities of the EU MDR.
To find qualified vetted providers [click here](https://cruxi.ai/regulatory-directories/prrc_service) and request quotes for free.
### Key EU MDR References
For manufacturers seeking to understand the requirements for the PRRC, it is essential to consult the official regulatory texts and guidance. Key documents include:
* **EU Medical Device Regulation (2017/745):** Specifically Article 15, which defines the role, responsibilities, and qualification requirements for the Person Responsible for Regulatory Compliance.
* **MDCG 2019-7 Rev. 1:** Guidance on Article 15 of the Medical Device Regulation and In Vitro Diagnostic Device Regulation regarding the Person Responsible for Regulatory Compliance (PRRC).
* **EN ISO 13485:2016:** While not an EU regulation, this harmonized standard for medical device quality management systems provides the framework into which the PRRC's activities must be integrated.
Sponsors should always refer to the latest versions of these documents available from official European Commission sources.
***
This article is for general educational purposes only and is not legal, medical, or regulatory advice. For device-specific questions, sponsors should consult qualified experts and consider engaging FDA via the Q-Submission program.
---
*This answer was AI-assisted and reviewed for accuracy by Lo H. Khamis.*